Grace Therapeutics, Inc. Deferred Tax Assets, Tax Credit Carryforwards
Grace Therapeutics, Inc. (GRCE) had Deferred Tax Assets, Tax Credit Carryforwards of $53.14 million as of 2024-03-31, per its 10-K filed 2024-06-21.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsTaxCreditCarryforwards · last filed 2024-06-21
- 2024-03-31: Deferred Tax Assets, Tax Credit Carryforwards $53.14M.
- 2023-03-31: Deferred Tax Assets, Tax Credit Carryforwards $51.64M; Deferred Tax Assets, Tax Credit Carryforwards as first filed $3.95M.
- 2022-03-31: Deferred Tax Assets, Tax Credit Carryforwards $3.33M.
- 2021-03-31: Deferred Tax Assets, Tax Credit Carryforwards $2.97M.
| Period end | Deferred Tax Assets, Tax Credit Carryforwards | Deferred Tax Assets, Tax Credit Carryforwards as first filed |
|---|---|---|
| 2024-03-31 | $53.14M 10-K · filed 2024-06-21 | |
| 2023-03-31 | $51.64M 10-K · filed 2024-06-21 | $3.95M 10-K · filed 2023-06-23 |
| 2022-03-31 | $3.33M 10-K · filed 2023-06-23 | |
| 2021-03-31 | $2.97M 10-K · filed 2022-06-21 | |
| 2020-03-31 | $2.47M 10-K · filed 2021-06-22 | |
| 2019-03-31 | $2.46M 10-K · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |